DEFINING EARLY HEALTH TECHNOLOGY ASSESSMENT: BUILDING CONSENSUS USING DELPHI TECHNIQUE: A commentary on implementation and diffusion of early HTA [0.03%]
明确早期卫生技术评估：使用德尔菲技术达成共识：对早期HTA实施和推广的评论
Linn Nathalie Støme
Linn Nathalie Støme
DEVELOPMENT AND VALIDATION OF A TYPE 2 DIABETES MODEL TO ESTIMATE THE COST-EFFECTIVENESS OF DIABETES INTERVENTIONS ACROSS THE CARE CONTINUUM [0.03%]
用于估算糖尿病照护全程中各种干预措施的成本效果的2型糖尿病模型的研发与验证
Megan Wiggins,Jeff Round,Erin Kirwin
Megan Wiggins
Iben Fasterholdt,Tue Kjølhede,Lise Kvistgaard Jensen
Iben Fasterholdt
DEFINING EARLY HEALTH TECHNOLOGY ASSESSMENT: BUILDING CONSENSUS USING DELPHI TECHNIQUE [0.03%]
界定早期卫生技术评估：使用德尔菲技术达成共识
Janneke P C Grutters,Janet Bouttell,Payam Abrishami et al.
Janneke P C Grutters et al.
Identifying characteristics for a cost-effective psoriatic arthritis biomarker test: a development-focused health technology assessment [0.03%]
低成本银屑病关节炎生物标志物检测的特点识别：以研发为导向的技术评估
Alexander C T Tam,Vinod Chandran,Dafna Gladman et al.
Alexander C T Tam et al.
Objectives: This study aimed to evaluate the required test characteristics that a psoriatic arthritis (PsA) biomarker test would need to achieve to be considered cost-effective. ...
Yumei He,Wei Li,Xiaochen Zhu et al.
Yumei He et al.
Julie L Hoang,Jeffrey J Sine,Sweta Saxena et al.
Julie L Hoang et al.
The role and value of real-world evidence in health technology decision-making in France, Germany, Italy, Spain, and the UK: insights on external control arms [0.03%]
真实世界证据在法国、德国、意大利、西班牙和英国的卫生技术决策中的作用与价值：对外部对照臂的启示
Alexa Vidalis,Oscar Dumoulin,Mrunmayee Godbole et al.
Alexa Vidalis et al.
Real-world evidence (RWE) is increasingly used and accepted by health technology assessment (HTA) bodies as supportive evidence to inform the approval of new technologies. However, the criteria driving RWE acceptance are often unclear.This ...